Login
Register

Therapeutic Areas
Products
GCC Cast
Resources
- PMR Callback
- MSD Manuals
About Us

Melanoma ESMO 2024 (Qatar)

ESMO 2024 reveals further support for the use of KEYTRUDA® for stage II and III melanoma

Login or register to access this content.

Login

Loading...

Need an account? Register

What can we help you find?

Search for

Contact Us
Terms of Use
Privacy Policy
Site Map
Accessibility

GULF Copyrights:
Copyright © 2026 Merck & Co., Inc., Rahway, NJ, USA and its affiliates.

All rights reserved.

AE-NON-00555 | Exp: 12 June 2027
To report an adverse event, product quality complaint and other reportable information or if you have a medical inquiry, you can contact: Tel: +9714 4269100 Fax: +9714 4269204

Email: DPOC.GULF@MSD.COM

KSA Copyrights:
Copyright © 2026 Merck Sharp & Dohme Corp., MSD Saudi Arabia is a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.

AE-NON-00555 | Exp: 12 June 2027
To report an adverse event, product quality complaint and other reportable information or if you have a medical inquiry, you can contact: Tel: +966112506700 Fax: +966 11 2506870
Email: DPOC.SAUDI@MSD.COM
MSD Building #3, Business Gate, Airport Road, Qurtubah, Riyadh 13244 PO Box 17098 Saudi Arabia.

This site uses cookies. To find out more about the cookies this site uses and how to manage them, please review the cookies section of our Privacy Policy. By using the site, you agree to our use of cookies.